Joint Pain Holding You Back? Discover how Collagen Peptide + Glucosamine + Chondroitin Tablets restore mobility while unlocking lucrative PCD pharma franchise opportunities.
Collagen Peptide Type I (40mg) delivers bioavailable peptides that stimulate cartilage regeneration, while Glucosamine Sulphate (500mg) and Chondroitin Sulfate (200mg) rebuild the joint matrix by fueling glycosaminoglycan production. Sodium Hyaluronate (30mg) lubricates synovial fluid, Vitamin C (35mg) powers collagen synthesis, and Zinc (22.5mg) accelerates tissue repair. B-vitamins and Vitamin A (2500 IU) support cellular energy metabolism.
Perfect for osteoarthritis, rheumatoid arthritis, post-injury recovery, and age-related joint degeneration.
Glucosamine blocks destructive enzymes (MMPs) while providing cartilage building blocks. Chondroitin retains water for joint cushioning and inhibits inflammatory cytokines. Collagen peptides trigger chondrocyte activity via matrikine signaling, producing type II collagen. Hyaluronic acid reduces friction, while micronutrients prevent co-factor deficiencies that impair repair.
Result: Structural cartilage rebuilding + inflammation control + lubrication restoration.
PCD pharma franchise model offers:
Target audience: Rheumatologists, orthopedicians, sports medicine specialists, wellness centers.
India's osteoarthritis market: 15% CAGR, driven by aging population + sports injuries.
Third party manufacturing advantages:
Production highlights:
Differentiators:
Marketing channels:
"Joint care = recession-proof pharma segment. Launch with ortho specialists first, expand to GPs.beats distribution models with 3x margins," says Pharma Business Consultant.
Pro Tips:
Ready to capture the Rs. 500 Cr joint care market? Connect with PCD pharma franchise providers or third party manufacturing partners today—secure your joint health business empire!
